Search

Surendra M Gupta

from Walnut Creek, CA
Age ~49
Get Report
Also known as:
Surendra Guptaa, Surenbra Gubba, Surendra A
Related to:
Ajay Gupta, 46
Connected to:
Aarushi Gupta, 36Abhas Gupta, 43Ajeya Gupta, 33Ajit Gupta, 62Akanksha Gupta, 42Aman S Gupta, 46Amar Gupta, 39Ambarish Gupta, 41Amita Gupta, 55Amruta Gupta, 57

Surendra Gupta Phones & Addresses

  • Walnut Creek, CA
  • Concord, CA
  • Torrance, CA
  • Cerritos, CA
  • 1382 Walnut St, Tustin, CA 92780 (714) 486-3947
  • Lake Forest, CA
  • Milpitas, CA
  • 20710 Anza Ave APT 23, Torrance, CA 90503

Professional Records

Medicine Doctors

Surendra Gupta Photo 1

Surendra K. Gupta

View page
Specialties:
Nephrology
Work:
South Queens Dialysis Center
17537 Liberty Ave, Jamaica, NY 11433
(718) 297-9100 (phone), (718) 297-0625 (fax)

Fresenius Medical Care Queens Artificial Kidney Center
3435 70 St, Jackson Heights, NY 11372
(718) 651-9700 (phone), (718) 533-0264 (fax)

Saint Albans Dialysis Center Jamaica
17270 Baisley Blvd, Jamaica, NY 11434
(718) 949-1600 (phone), (718) 525-9363 (fax)
Education:
Medical School
Maulana Azad Med Coll, Delhi Univ, New Delhi, Delhi, India
Graduated: 1967
Procedures:
Dialysis Procedures
Conditions:
Acute Renal Failure
Chronic Renal Disease
Anemia
Calculus of the Urinary System
Diabetes Mellitus (DM)
Languages:
English
Description:
Dr. Gupta graduated from the Maulana Azad Med Coll, Delhi Univ, New Delhi, Delhi, India in 1967. He works in Jamaica, NY and 2 other locations and specializes in Nephrology. Dr. Gupta is affiliated with Forest Hills Hospital and Mount Sinai Queens.

Business Records

Name / Title
Company / Classification
Phones & Addresses
Surendra K. Gupta
President
HEALTHCARE.COM INCORPORATED
Home Health Care Services
16 Lndg, Laguna Niguel, CA 92677
(949) 249-3566
Surendra K. Gupta
President
HN BIOTECH, INC
Business Services at Non-Commercial Site
11601 Wilshire Blvd STE 500, Los Angeles, CA 90025
16 Lndg, Laguna Beach, CA 92677

Publications

Us Patents

Method And Test Strips For The Measurement Of Fat Loss During Weight Loss Programs

View page
US Patent:
6762035, Jul 13, 2004
Filed:
Feb 4, 2002
Appl. No.:
10/067660
Inventors:
Surendra K. Gupta - Laguna Niguel CA, 92677
International Classification:
C12Q 132
US Classification:
435 26, 435 4, 435829, 435968, 435970
Abstract:
A method for monitoring the progress of fat loss in a patient during a weight loss program which comprises, contacting a body fluid sample from said patient with a solid test strip to provide a color indication of the presence in said body fluid of -hydroxybutyrate, optionally together with acetoacetate and/or acetone.

Method And Test Strips For The Measurement Of Fat Loss During Weight Loss Programs

View page
US Patent:
20040043376, Mar 4, 2004
Filed:
Aug 25, 2003
Appl. No.:
10/646763
Inventors:
Surendra Gupta - Laguna Niguel CA, US
International Classification:
C12Q001/00
C12Q001/32
US Classification:
435/004000, 435/026000
Abstract:
Disposable test strips and a wet chemistry method for measuring each of -hydroxybutyrate alone, combined -hydroxybutyrate and acetoacetate or total ketone bodies (i.e., -hydroxybutyrate, acetoacetate and acetone) in human bodily fluid samples, including but not limited to urine, saliva or sweat are described. The test strips need only be dipped in the sample and can be used by anyone in almost any milieu. Measurement can be made electrochemically, spectrophotometrically, fluorometrically or by comparision to a color standard. Combined acetoacetate and -hydroxybutyrate which account for 97-98% of total ketone bodies and may be measured in a cyclic reaction that occurs at pH about 7.0 to about 8.3 with -hydroxybutyrate dehydrogenase, (-HBD), nicotinamide adenine dinucleotide, a tetrazolium dye precursor and an electron mediator. Using this reaction, false positive results obtained from urine samples taken from patients on sulfhydryl drugs are avoided. -HBD from some sources was found to cause false negative results in samples (e.g. urine) containing high chloride content due to chloride inhibition of -HBD. Using a simple test for chloride inhibition, it was found that -HBD from Alcaligenes is not so inhibited. Using either -HBD that is not inhibited by chloride or using 10-20 times the normal concentration of this enzyme eliminates false negatives in samples having substantial chloride content, such as urine, both in the reaction described above and in other reactions disclosed for measuring each of -hydroxybutyrate alone, combined -hydroxybutyrate and acetoacetate and total ketone bodies, all of which reactions occur in the pH range of about 8.6 to about 9.5.

Test Device For Simultaneous Measurement Of Multiple Analytes In A Single Sample

View page
US Patent:
20050214161, Sep 29, 2005
Filed:
Mar 23, 2004
Appl. No.:
10/806461
Inventors:
Surendra Gupta - Laguna Niguel CA, US
International Classification:
G01N031/22
US Classification:
422056000
Abstract:
The invention consists of a test device for simultaneous measurement of multiple analytes in one sample where the liquid sample is applied to a matrix at the central area of the device which is connected to multiple arms, and each of the arms contains specific reagents in dry form for measurement of a particular analyte. The sample travels from the center uniformly and quickly to the reagent site on each arm and produces a measurable signal that may be a change in electrical charge or current, fluorescence, or, preferably, color. A color change can be detected visually or measured quantitatively using a suitable reflectance meter. The sample may be a small amount of whole blood obtained e.g., from a finger puncture or it may be urine, saliva, any other bodily fluid, environmental water, or any other fluid upon which rapid, simultaneous testing of levels of different components is desired. According to the invention, a disease specific panel for kidney, liver, heart, lipid disorders or for early detection of dysfunction of general health can be performed at or near the patients' site and can provide instant results. Similarly, rapid simultaneous testing of water samples is desirable under many circumstances.

Apolipoprotein C-Ii Or Its Active Fractions For The Prevention Or Treatment Of Obesity And Related Metabolic Disorders

View page
US Patent:
20110230398, Sep 22, 2011
Filed:
Mar 19, 2010
Appl. No.:
12/727339
Inventors:
Surendra K. Gupta - Laguna Niguel CA, US
International Classification:
A61K 38/00
C07K 14/00
C07K 2/00
A61P 3/04
US Classification:
514 48, 530350, 530300, 514 69, 514 74
Abstract:
Apoliporotein C-II or any active fraction of its amino acid sequence that activates lipoprotein lipase (LPL) in mammals. Increase in activity of LPL can increase expenditure of energy, and therefore an activator of LPL can be an effective agent for the prevention or treatment of obesity or related metabolic disorders, including cardiovascular disease, diabetes and hypertension in mammals including domestic pets and humans. Apolipoprotein C-II or its active fractions can be used as a diet supplement in the form of fortification to a natural product such as milk, cereal, beverage; as a nutritional supplement; or as a therapeutic agent in conventional forms of administration.

Isbn (Books And Publications)

Conflict and Communication: Mass Upsurge in Assam

View page
Author

Surendra K. Gupta

ISBN #

0706952359

Stalin's Policy Towards India 1946-1953

View page
Author

Surendra K. Gupta

ISBN #

8170030935

Emerging Social Science Concerns: Festschrift in Honour of Professor Yogesh Atal

View page
Author

Surendra K. Gupta

ISBN #

8180690989

Environmentally Conscious Manufacturing 4

View page
Author

Surendra M. Gupta

ISBN #

0819455369

Environmentally Conscious Manufacturing

View page
Author

Surendra M. Gupta

ISBN #

0819460214

Control profile
Surendra M Gupta from Walnut Creek, CA, age ~49 Get Report